“Evaluation of Inflammatory and Biochemical Markers in COVID-19 Patients Treated With Tocilizumab Alone or With the Combination of Tocilizumab and Convalescent Plasma Transfusion”. Annals of Medical Research, vol. 29, no. 7, July 2022, pp. 770-6, http://annalsmedres.org/index.php/aomr/article/view/4231.